SB 1344 creates Oklahoma's Insulin Access and Affordability Program, administered by the State Department of Health, to increase access to affordable insulin for residents. The bill requires the Department to provide financial support to a nonprofit pharmaceutical manufacturer developing fast-acting biosimilar insulin, contingent on the manufacturer matching funds and agreeing to produce insulin at low cost without rebates (except as required by law). The agreement includes annual reporting on development progress and repayment terms if the insulin isn't produced and distributed as promised. This program directly affects Oklahoma residents needing insulin, public and private payors, and the specified nonprofit manufacturer.
SB 1134 allocates $100,000 from Oklahoma's General Revenue Fund to the Oklahoma Health Care Authority for the 2026 fiscal year. The bill directly provides funding for the Authority to carry out its legal duties. It declares an emergency to allow immediate implementation upon passage. This is a procedural appropriations measure with no policy changes beyond the specified funding amount.
SB 1142 allocates $100,000 from unallocated state funds to Oklahoma's Department of Mental Health and Substance Abuse Services for the 2025-2026 fiscal year. The funding is intended to support the department's existing duties, including providing mental health and substance abuse services to Oklahomans. The bill declares an emergency to allow immediate implementation upon approval, bypassing standard legislative timelines. This is a procedural funding measure, not a policy change, and remains pending before the Appropriations Committee.
HB 2947 adds a new provider code in Oklahoma Medicaid for master's and doctoral-level behavioral health clinical interns. These interns - graduate students in nationally accredited programs - can provide services under the direct supervision of licensed behavioral health providers (like LPCs or LCSWs) while following all Medicaid documentation and training requirements. The bill directly affects interns seeking practical experience and licensed supervisors who will oversee their Medicaid-covered services. It expands Medicaid access to behavioral health care by formalizing intern participation in the state's Medicaid plan.
SB 2074 requires pharmacy benefit managers (PBMs) to accept all documentation from pharmacies when challenging reimbursement amounts and include specific details in appeal requests. If an appeal is approved, PBMs must adjust payments within 14 days and provide claim-level details. The bill applies to all PBMs working with Oklahoma pharmacies and covers disputes over reimbursement rates for prescription drugs. It aims to streamline the appeals process and prevent delays in payments to pharmacies.
HB 3901 establishes a pilot program for psychological autopsies in Oklahoma, which investigate ambiguous deaths (like suicides) to reconstruct a deceased person's mental state and influences. The Commissioner of Health must appoint a full-time psychological autopsy examiner who will submit annual progress reports and coordinate with mental health and medical examiner offices. The pilot runs until November 1, 2031, with a recommendation for permanency or termination. Its goal is to use data from these reviews to inform suicide prevention efforts, without changing existing laws or creating new obligations for individuals.
HB 2834 requires Oklahoma's Medicaid program to cover 96% of Medicare's payment rates for in-home physical, occupational, and speech therapy services. This directly affects Oklahoma Medicaid recipients needing these specific therapies by ensuring providers receive a standardized reimbursement rate. The bill sets a new reimbursement standard for these services, effective July 1, 2025, rather than expanding eligibility. It passed the Oklahoma House of Representatives with 64-25 support but did not secure emergency status.
HB 3130 prohibits Oklahoma state agencies, contractors, and public institutions from using state funds for gender transition procedures for minors, including allocation, referral, or contracting with providers offering such care. It also protects parents' rights by stating that withholding consent for gender transition procedures does not constitute child abuse or grounds for losing custody. The bill amends medical licensure laws to classify aiding or abetting gender transition procedures as unprofessional conduct, subjecting medical professionals to disciplinary action by licensing boards. These provisions apply directly to state-funded healthcare providers, minors receiving medical care, and licensed physicians or medical staff.
HB 4490 creates the Oklahoma Families Thriving Everywhere Now (OFTEN) program through the Oklahoma State Department of Health, using $3 million in state funds for the 2027 fiscal year. The program provides telecare support, community outreach, and care coordination for women with high-risk pregnancies and parents of children under three, aiming to promote healthy childbirth, stable family formation, and economic self-sufficiency. Services include referrals, case management, and parenting assistance delivered by Oklahoma-based community providers. The bill takes effect July 1, 2026, and includes an emergency declaration to accelerate implementation.
HB 1912, the "Corn Masa Nutrition Enhancement Act," requires corn masa flour and wet corn masa products sold in Oklahoma to contain specific folic acid levels starting January 1, 2026: 0.7 mg per pound for corn masa flour and 0.4 mg per pound for wet corn masa products. Manufacturers must also label these products to declare folic acid content per federal standards and specify whether they contain corn masa flour or were made via wet corn masa processing. The law exempts cottage food operations, food facilities, and small-volume operators from these requirements, and explicitly excludes snack foods (like chips) from the rules. The bill becomes effective November 1, 2025, with compliance beginning January 1, 2026.
